Leptin induces cell migration and the expression of growth factors in human prostate cancer cells

American Journal of Surgery

Volumn 188, Issue 5, 2004, Pages 560-565

  Frankenberry, Krista A ^a   Somasundar, Ponnandai ^b   McFadden, David W ^a   Vona Davis, Linda C ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Growth factors; Leptin; Migration; Prostate cancer

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HORMONE; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; LEPTIN; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; PROSTATIC NEOPLASMS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 8544260325     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2004.07.031     Document Type: Article

References (25)

1. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
2. K.K. Carroll Obesity as a risk factor for certain types of cancer Lipids 33 1998 1055 1059
3. A.I. Neugut, A.C. Chen, D.P. Petrylak The "skinny" on obesity and prostate cancer prognosis J Clin Oncol 22 2004 395 398
4. P. Somasundar, D.W. McFadden, S.M. Hileman, L.C. Vona-Davis Leptin is a growth factor in cancer J Surg Res 116 2004 337 349
5. R.V. Considine, M.K. Sinha, M.L. Heiman Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 1996 292 295
6. M.R. Sierra-Honigmann, A.K. Nath, C. Murakami Biological action of leptin as an angiogenic factor Science 281 1998 1683 1686
7. P. Somasundar, K. Frankenberry, H. Skinner Prostate cancer cell proliferation is influenced by leptin J Surg Res 118 2004 71 82
8. P. Somasundar, A. Yu, L. Vona-Davis, D.W. McFadden Differential responses of leptin on cancer in vitro J Surg Res 113 2002 50 55
9. Vona-Davis L, Riggs D, Jackson B, McFadden DW. Leptin suppresses apoptosis in prostate cancer in vitro. American Association for Cancer Research 2003 Annual Meeting. Washington DC, American Association for Cancer Research, 2003, Abstract no. 393.
10. D. Strohmeyer, C. Rossing, A. Bauerfeind Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer Prostate 45 2000 216 224
11. F.A. Ferrer, L.J. Miller, R.I. Andrawis Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells Urology 51 1998 161 167
12. P.J. Hepburn, K. Griffiths, M.E. Harper Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro Prostate 33 1997 123 132
13. Y. Tokuda, Y. Satoh, C. Fujiyama Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction Brit J Urol 91 2003 716 720
14. H.Y. Park, H.M. Kwon, H.J. Lim Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro Exp Mol Med 33 2001 95 9102
15. E. Glynne-Jones, M.E. Harper, L. Goddard Transforming growth factor beta 1 expression in benign and malignant prostatic tumors Prostate 25 1994 210 218
16. L.D. Truong, D. Kadmon, B.K. McCune Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study Hum Pathol 24 1993 4 9
17. H.L. Adler, M.A. McCurdy, M.W. Kattan Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma J Urol 161 1999 182 187
18. V. Ivanovic, A. Melman, B. Davis-Joseph Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer Nat Med 1 1995 282 284
19. G.E. Meyer, E. Yu, J.A. Siegal Serum basic fibroblast growth factor in men with and without prostate carcinoma Cancer 76 1995 2304 2311
20. M.V. Cronauer, A. Hittmair, I.E. Eder Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate Prostate 31 1997 223 233
21. M.S. Pepper, S.J. Mandriota, J.D. Vassalli Angiogenesis-regulating cytokines: activities and interactions Curr Top Microbiol Immunol 213 1996 31 67
22. T. Nakamoto, C.S. Chang, A.K. Li, G.W. Chodak Basic fibroblast growth factor in human prostate cancer cells Cancer Res 52 1992 571 577
23. Trojan L, Thomas D, Knoll T, et al. Expression of pro- angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer. Urol Res 2004 (in press).
24. N. Weidner, P.R. Carroll, J. Flax Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 143 1993 401 409
25. S. Attoub, V. Noe, L. Pirola Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways FASEB J 14 2000 2329 2338